Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue ...
CAMBRIDGE, MA / ACCESS Newswire / November 20, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it has closed a five-year ...
Moderna's chief technical operations officer explains why now is the right time to take full control of the company's ...
Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...
With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...
The new line of credit could ease pressure on the money-losing vaccine maker as it tries to chart its post-pandemic future.
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...
New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...
TipRanks on MSN
Moderna Secures $1.5 Billion Credit Facility
Moderna ( ($MRNA) ) just unveiled an update. On November 19, 2025, Moderna, Inc. entered into a Credit and Guaranty Agreement providing a $1.5 ...
TipRanks on MSN
Moderately bullish activity in Moderna with shares up 2.55%
Moderately bullish activity in Moderna (MRNA), with shares up 62c, or 2.55%, near $24.77. Options volume relatively light with 58k contracts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback